Evidence map›Paper›PMID 41953098›Full record

ArticleClinical case reports2026

Metastatic Prostate Cancer Masquerading as Locally Advanced Breast Cancer.

Tess Howard, Mylestone Gobe Monna, Jasmine Zhu, Jiasian Teh, Sze Ting Lee, Grace L Chew

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tess HowardDepartment of General Surgery Austin Health Melbourne Australia.ORCID https://orcid.org/0000-0002-8753-8545
Mylestone Gobe MonnaDepartment of General Surgery Austin Health Melbourne Australia.
Jasmine ZhuDepartment of Anatomical Pathology Austin Health Melbourne Australia.
Jiasian TehDepartment of Urology Austin Health Melbourne Australia.
Sze Ting LeeDepartment of Nuclear Medicine Austin Health Melbourne Australia.
Grace L ChewDepartment of General Surgery Austin Health Melbourne Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a rare case of a 72-year-old man with prostatic adenocarcinoma metastasizing to gynecomastia breast tissue with ipsilateral axillary lymph node involvement. This presentation is notable for the absence of disseminated metastatic disease or prolonged androgen deprivation therapy. The clinical and radiological features initially suggested a primary breast carcinoma, highlighting the diagnostic challenge in such presentations. The patient had a history of high-risk prostate adenocarcinoma resected in 2020. A prostate-specific membrane antigen (PSMA) PET scan, performed for rising prostate-specific antigen (PSA) levels, demonstrated a new avid left breast lesion within longstanding bilateral gynecomastia tissue. The pattern of PSMA uptake, including involvement of ipsilateral axillary lymph nodes, further increased suspicion for a locally advanced primary breast carcinoma. Core biopsy of the breast lesion and fine-needle aspiration of the axillary lymph node were consistent with metastatic prostate adenocarcinoma, which was subsequently confirmed on surgical excision. This case adds to the limited literature describing prostate cancer metastasis to the breast and underscores the diagnostic challenges such presentations can create. It demonstrates how metastatic disease can closely mimic primary breast malignancy, reinforcing the importance of histopathological confirmation when imaging findings suggest a primary breast lesion.

Indexed as

breast neoplasms secondarygynecomastiapositron emission tomographyprostatic neoplasms

Identifiers

PMID41953098
PMCPMC13053294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.